Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Neurological Sciences
Published in: Neurological Sciences 10/2021

01-10-2021 | Cranial MRI | COVID-19

Anti-GAD associated post-infectious cerebellitis after COVID-19 infection

Authors: Ahmed Serkan Emekli, Asuman Parlak, Nejla Yılmaz Göcen, Murat Kürtüncü

Published in: Neurological Sciences | Issue 10/2021

Login to get access

Abstract

The coronavirus disease 2019 (COVID-19), caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to spread rapidly all over the world. Besides severe pneumonia, it causes multisystemic disease, including neurological findings. Here, we present a patient with anti–glutamic acid decarboxylase (anti-GAD) antibody-associated cerebellitis developed after COVID-19 infection. The patient responded well to the immune treatments. Our knowledge about SARS-CoV-2 infection–related neurological disorders is limited. New data are needed to recognize the clinical spectrum of autoimmune neurological disorders that emerges after SARS-CoV-2 infection.
Literature
1.
Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC (2020) Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA 324:782–793CrossRef
2.
Mitoma H, Manto M, Hampe CS (2018) Immune-mediated cerebellar ataxias: practical guidelines and therapeutic challenges. Curr Neuropharmacol 17:33–58CrossRef
3.
Manto M, Mitoma H, Hampe CS (2019) Anti-GAD antibodies and the cerebellum: where do we stand? Cerebellum 18:153–156CrossRef
4.
5.
Saha B, Saha S, Chong WH (2021) 78-year-old woman with opsoclonus myoclonus ataxia syndrome secondary to COVID-19. BMJ Case Rep. 14:e243165.
6.
7.
Werner J, Reichen I, Huber M, Abela IA, Weller M, Jelcic I (2021) Subacute cerebellar ataxia following respiratory symptoms of COVID-19: a case report. BMC Infect Dis 21:1–7CrossRef
8.
Sharma S, Ruparelia J, Bhaskar S, Tiwari S, Nag VL, Panda S (2021) Acute fulminant cerebellitis in children with COVID-19 infection: a rare but treatable complication. Pediatr Neurol 119:45–47CrossRef
9.
10.
11.
Urrea-Mendoza E, Okafor K, Ravindran S, Absher J, Chaubal V, Revilla FJ (2021) Opsoclonus-myoclonus-ataxia syndrome (Omas) associated with sars-cov-2 infection: post-infectious neurological complication with benign prognosis. Tremor and Other Hyperkinetic Movements 11:1–4CrossRef
12.
13.
Foucard C, San-Galli A, Tarrano C, Chaumont H, Lannuzel A, Roze E (2021) Acute cerebellar ataxia and myoclonus with or without opsoclonus: a parainfectious syndrome associated with COVID‐19. Eur J Neurol. 0–3 (Online ahead of print). doi: https://​doi.​org/​10.​1111/​ene.​14726.
14.
Shah PB, Desai SD (2021) Opsoclonus myoclonus ataxia syndrome in the setting of COVID-19 infection. Neurology 96:33CrossRef
15.
Emamikhah M, Babadi M, Mehrabani M, Jalili M, Pouranian M, Daraie P et al (2021) Opsoclonus-myoclonus syndrome, a post-infectious neurologic complication of COVID-19: case series and review of literature. J Neurovirol 27:26–34CrossRef
16.
Shetty K, Jadhav AM, Jayanthakumar R, Jamwal S, Shanubhogue T, Reddy MP et al (2021) Myoclonus-ataxia syndrome associated with COVID-19. J Mov Disord 14:153–156CrossRef
17.
Grimaldi S, Lagarde S, Harlé JR, Boucraut J, Guedj E (2020) Autoimmune encephalitis concomitant with SARS-CoV-2 infection: insight from 18F-FDG PET imaging and neuronal autoantibodies. J Nucl Med 61:1726–1729CrossRef
18.
Povlow A, Auerbach AJ (2021) Acute cerebellar ataxia in COVID-19 infection: a case report. J Emerg Med 60:73–76CrossRef
19.
Wright D, Rowley R, Halks-Wellstead P, Anderson T, Wu TY (2020) Abnormal saccadic oscillations associated with severe acute respiratory syndrome coronavirus 2 encephalopathy and ataxia. Mov Disord Clin Pract 7:980–982CrossRef
20.
de Marcaida JA, Lahrmann J, Machado D, Bluth L, Dagostine M, Moro-de Casillas M et al (2020) Clinical characteristics of coronavirus disease 2019 (COVID-19) among patients at a movement disorders center. Geriatr 5:54CrossRef
21.
Dijkstra F, Van den Bossche T, Willekens B, Cras P, Crosiers D (2020) Myoclonus and cerebellar ataxia following COVID-19. Mov Disord Clin Pract 7:974–976CrossRef
22.
Schellekens MMI, Bleeker-Rovers CP, Keurlings PAJ, Mummery CJ, Bloem BR (2020) Reversible myoclonus-ataxia as a postinfectious manifestation of COVID-19. Mov Disord Clin Pract 7:977–979CrossRef
23.
Delorme C, Paccoud O, Kas A, Hesters A, Bombois S, Shambrook P et al (2020) COVID-19-related encephalopathy: a case series with brain FDG-positron-emission tomography/computed tomography findings. Eur J Neurol 27:2651–2657CrossRef
24.
Diezma-Martín AM, Morales-Casado MI, García Alvarado N, Vadillo Bermejo A, López-Ariztegui N, Sepúlveda Berrocal MA (2020) Tremor and ataxia in COVID-19. Neurologia (Engl Ed) 35:409–410CrossRef
25.
Fadakar N, Ghaemmaghami S, Masoompour SM, Shirazi Yeganeh B, Akbari A, Hooshmandi S et al (2020) A first case of acute cerebellitis associated with coronavirus disease (COVID-19): a case report and literature review. Cerebellum 19:911–914CrossRef
26.
Dade M, Berzero G, Izquierdo C, Giry M, Benazra M, Delattre JY et al (2020) Neurological syndromes associated with anti-gad antibodies. Int J Mol Sci 21:3701CrossRef
27.
Kaur RJ, Charan J, Dutta S, Sharma P, Bhardwaj P, Sharma P et al (2020) Favipiravir use in COVID-19: Analysis of suspected adverse drug events reported in the WHO database. Infect Drug Resist 13:4427–4438CrossRef
28.
Panariello A, Bassetti R, Radice A, Rossotti R, Puoti M, Corradin M et al (2020) Anti-NMDA receptor encephalitis in a psychiatric Covid-19 patient: A case report. Brain Behav Immun 87:179–181CrossRef
29.
Monti G, Giovannini G, Marudi A, Bedin R, Melegari A, Simone AM et al (2020) Anti-NMDA receptor encephalitis presenting as new onset refractory status epilepticus in COVID-19. Seizure 81:18–20CrossRef
30.
Guilmot A, Maldonado Slootjes S, Sellimi A, Bronchain M, Hanseeuw B, Belkhir L et al (2021) Immune-mediated neurological syndromes in SARS-CoV-2-infected patients. J Neurol 268:751–757CrossRef
31.
Paterson RW, Brown RL, Benjamin L, Nortley R, Wiethoff S, Bharucha T et al (2020) The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain 143:3104–3120CrossRef
Metadata
Title
Anti-GAD associated post-infectious cerebellitis after COVID-19 infection
Authors
Ahmed Serkan Emekli
Asuman Parlak
Nejla Yılmaz Göcen
Murat Kürtüncü
Publication date
01-10-2021
Publisher
Springer International Publishing
Published in
Neurological Sciences / Issue 10/2021
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-021-05506-6

Other articles of this Issue 10/2021

Neurological Sciences 10/2021 Go to the issue

Original Article

Insertable cardiac monitors for detection of atrial fibrillation after cryptogenic stroke: a meta-analysis

COVID-19

Functional neurological disorder after COVID-19 vaccination

Original Article

Shear wave elastography characteristics of upper limb muscle in rigidity-dominant Parkinson’s disease

Original Article

Numerical Activities of Daily Living – Financial: a short version

Letter to the Editor

A new phenotype of MT-ND6 gene mutation for Leber’s hereditary optic neuropathy

Review Article

Rescue therapies for seizure emergencies: current and future landscape